{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:04:35Z","timestamp":1710248675314},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":1366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.anpedi.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T09:40:55Z","timestamp":1412847655000},"page":"198.e1-198.e9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vacunaci\u00f3n frente al meningococo B. Posicionamiento del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda"],"prefix":"10.1016","volume":"82","author":[{"given":"D.","family":"Moreno-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ar\u00edstegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Corretger Rauet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Garc\u00eda S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hern\u00e1ndez Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hern\u00e1ndez-Sampelayo Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2014.09.004_bib0005","doi-asserted-by":"crossref","unstructured":"Moreno-P\u00e9rez D, \u00c1lvarez Garc\u00eda FJ, Ar\u00edstegui Fern\u00e1ndez J, Cilleruelo Ortega MJ, Corretger Rauet JM, Garc\u00eda S\u00e1nchez N, et al., en representaci\u00f3n del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda, Espa\u00f1a. Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2015. An Pediatr (Barc). 2015. En prensa.","DOI":"10.1016\/j.anpedi.2014.10.019"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anpedi.2013.11.032","article-title":"El calendario de vacunaci\u00f3n com\u00fan de m\u00ednimos para Espa\u00f1a: posicionamiento del CAV-AEP","volume":"80","author":"Ar\u00edstegui Fern\u00e1ndez","year":"2014","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0015","unstructured":"European Medicine Agency (EMA). Bexsero [consultado 22 Ago 2014]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/002333\/human_med_001614.jsp&mid=WC0b01ac058001d124"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0020","unstructured":"Grupo de Trabajo MenB. Ponencia de Programas y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013. Vacuna frente a enfermedad meningoc\u00f3cica invasora por serogrupo B y su posible utilizaci\u00f3n en Salud P\u00fablica. Junio de 2013 [consultado 22 Ago 2014]. Disponible en: https:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenB.pdf"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0025","unstructured":"Informe de utilidad terap\u00e9utica de vacunas. Vacuna meningoc\u00f3cica del grupo B, Bexsero\u00ae. Fecha de elaboraci\u00f3n: 5 abril 2013[consultado 22 Ago 2014]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/vacunas\/infoUtilTerapeutica\/home.htm"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.vaccine.2013.12.027","article-title":"Approved but non-funded vaccines: Accessing individual protection","volume":"32","author":"Scheifele","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0035","unstructured":"European Centre Disease Control and Prevention (ECDC). Surveillance of invasive bacterial diseases in Europe, 2011 [consultado 22 Ago 2014]. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/invasive-bacterial-diseases-surveillance-2011.pdf"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anpedi.2014.02.015","article-title":"Prevenci\u00f3n de la enfermedad meningoc\u00f3cica por el serogrupo B mediante una vacuna de 4 componentes","volume":"80","author":"Gil","year":"2014","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0045","unstructured":"European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report: Reporting on 2011 surveillance data and 2012 epidemic intelligence data [consultado 22 Ago 2014]. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/annual-epidemiological-report-2013.pdf"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0050","unstructured":"Instituto de Salud Carlos III. Resultados de la vigilancia epidemiol\u00f3gica de las enfermedades transmisibles. A\u00f1o 2011 [consultado 22 Ago 2014]. Disponible en: http:\/\/gesdoc.isciii.es\/gesdoccontroller?action=download&id=14\/11\/2013-be6b0679b9"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOP.0b013e32832c9668","article-title":"Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents","volume":"21","author":"Brigham","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/INF.0000000000000282","article-title":"The clinical features and long-term sequelae of invasive meningococcal disease in children","volume":"33","author":"Stein-Zamir","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0070","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1016\/j.vaccine.2011.05.089","article-title":"The burden of hospitalizations for meningococcal infection in Spain (1997-2008)","volume":"29","author":"Gil-Prieto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0155","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2014.07.019","article-title":"Costs of surviving meningococcal disease in Spain: Evaluation for two cases of severe meningitis and septicaemia","volume":"32","author":"Darb\u00e0","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0080","unstructured":"Ficha t\u00e9cnica Bexsero\u00ae [consultado 22 Ago 2014]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/002333\/WC500137881.pdf"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0085","unstructured":"JCVI interim position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK. July 2013 [consultado 22 Ago 2014]. Disponible en: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224896\/JCVI_interim_statement_on_meningococcal_B_vaccination_for_web.pdf"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CmenB) in Europe: A qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0095","unstructured":"Abad R, Orlandi L, Rigat F, Boccadifuoco G, Comanducci M, Muzzi A, et al. Strain coverage of a meningococcal multicomponent (4CMenB) vaccine in Spain. 18th International Pathogenic Neisseria Conference. September 9-14, 2012, W\u00fcrzburg, Germany. Abstract 268."},{"issue":"7.","key":"10.1016\/j.anpedi.2014.09.004_bib0100","article-title":"A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I): Efects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB","volume":"10","author":"Prymula","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules. A randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0110","series-title":"8th World Congress of the WSPID","article-title":"Concomitant administration of meningococcal serogroup B vaccine with routine infant including rotavirus vaccines","author":"Dull","year":"2013"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0115","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Autorizaci\u00f3n de Bexsero\u00ae [consultado 22 Ago 2014]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verPresentaciones&codigo=112812001"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0120","unstructured":"JCVI position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK. 21st March 2014 [consultado 22 Ago 2014]. Disponible en: https:\/\/www.gov.uk\/government\/publications\/meningococcal-b-vaccine-jcvi-position-statement"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0125","unstructured":"German Standing Committee on Vaccination (STIKO). Statement on the new meningococcal serogroup B vaccine, Bexsero\u00ae. Robert Koch Institute. 9 diciembre 2013 [consultado 22 Ago 2014]. Disponible en: http:\/\/www.rki.de\/EN\/Content\/Prevention\/Vaccination\/recommandations\/STIKO_statement_Men_SgB.html"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0130","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Vaccination contre les infections invasives \u00e0 m\u00e9ningocoque B. Place du vaccin Bexsero\u00ae [consultado 22 Ago 2014]. Disponible en: http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=386"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0135","unstructured":"Advice for immunisation providers regarding the use of Bexsero\u00ae. Australian Technical Advisory Group on Immunisation (ATAGI) statement [consultado 22 Ago 2014]. Disponible en: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/atagi-advice-bexsero#full"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0140","unstructured":"Centers for Disease Control and Prevention. Princeton University Meningococcal Disease Outbreak [consultado 22 Ago 2014]. Disponible en: http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/princeton.html"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0145","unstructured":"Centers for Disease Control and Prevention. University of California, Santa Barbara Meningococcal Disease Outbreak [consultado 22 Ago 2014]. Disponible en: http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/ucsb.html"},{"key":"10.1016\/j.anpedi.2014.09.004_bib0150","unstructured":"Meningococcal B Pilot Project Task Group. National Advisory Committee on Immunization (NACI). Public Health Agency in Canada. The recommended us of the multicomponent meningococcal B (4CMenB) vaccine in Canada: common guidance statement. March 26, 2014 [consultado 22 Ago 2014]. Disponible en: http:\/\/www.phac-aspc.gc.ca\/naci-ccni\/mening-4cmenb-exec-resum-eng.php"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403314004287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403314004287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T01:35:53Z","timestamp":1565919353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403314004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1695403314004287"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2014.09.004","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunaci\u00f3n frente al meningococo B. Posicionamiento del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}